Savara
SVRA
#5916
Rank
A$1.50 B
Marketcap
A$7.41
Share price
-3.73%
Change (1 day)
63.50%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.14 Billion a decrease over its 2023 earnings that were of -A$78.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion30.89%
2024 -A$0.14 Billion75.29%
2023 -A$78.59 Million43.38%
2022 -A$54.82 Million-11.31%
2021 -A$61.8 Million-13.3%
2020 -A$71.29 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$98.73 Million105.54%
2017 -A$48.04 Million34.11%
2016 -A$35.82 Million-37.43%
2015 -A$57.25 Million38.81%
2014 -A$41.24 Million33.62%
2013 -A$30.87 Million38.49%
2012 -A$22.29 Million24.59%
2011 -A$17.89 Million-36.5%
2010 -A$28.17 Million-3.14%
2009 -A$29.09 Million-23.28%
2008 -A$37.91 Million8.52%
2007 -A$34.93 Million-34.14%
2006 -A$53.04 Million184.43%
2005 -A$18.65 Million90.75%
2004 -A$9.78 Million190.35%
2003 -A$3.37 Million11.64%
2002 -A$3.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.09 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA